Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series-Reference-Cited by-同舟云学术

Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series

Published:2017-02-15 Issue:2 Volume:23 Page:255-263
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Iorio A.¹^ORCID,Barbara A. M.¹,Makris M.²,Fischer K.³,Castaman G.⁴,Catarino C.⁵,Gilman E.²,Kavakli K.⁶,Lambert T.⁷,Lassila R.⁸,Lissitchkov T.⁹,Mauser-Bunschoten E.³,Mingot-Castellano M. E.¹⁰,Ozdemir N.¹¹,Pabinger I.¹²,Parra R.¹³,Pasi J.¹⁴,Peerlinck K.¹⁵,Rauch A.¹⁶,Roussel-Robert V.¹⁷,Serban M.¹⁸,Tagliaferri A.¹⁹,Windyga J.²⁰,Zanon E.²¹

Affiliation:

1. Department of Clinical Epidemiology and Biostastics; McMaster University; Hamilton ON Canada

2. Department of Infection, Immunity & Cardiovascular Disease; University of Sheffield; Sheffield UK

3. Van Creveldkliniek University Medical Centre Utrecht; Utrecht The Netherlands

4. San Bortolo Hospital; Vicenza Italy

5. Congenital Coagulopathies Centre; Santa Maria Hospital; Lisbon Portugal

6. Department of Pediatric Hematology; Ege University Children's Hospital; Izmir Turkey

7. Centre de traitement des Hemophiles de Bicetre; Paris France

8. Department of Hematology; Cancer Center; Helsinki University Hospital; Helsinki Finland

9. Haematology Hospital “Joan Pavel”; Sofia Bulgaria

10. Regional University Hospital of Málaga; Málaga Spain

11. Istanbul University Haemophilia Centre; Istanbul Turkey

12. Department of Medicine I; Haemophilia Centre; Medical University of Vienna; Vienna Austria

13. Hospital Vall d'Hebron; Barcelona Spain

14. Barts and the London School of Medicine; London UK

15. Haemophilia Center; Universitaire Ziekenhuis Gasthuisberg; Leuven Belgium

16. Département d'Hématologie Transfusion; Centre Hospitalier Régional Universitaire de Lille; Lille France

17. Regional Reference Centre for Inherited Bleeding Disorders; University Hospital of Parma; Parma Italy

18. Hôpital Cochin; Paris France

19. European Haemophilia Center; Paediatric Clinical Emergency Hospital Louis Turcanu; Timisoara Romania

20. Department of Disorders of Haemostasis and Internal Medicine; Institute of Haematology & Transfusion Medicine; Warsaw Poland

21. Haemophilia Centre; Azienda Universitaria Ospedaliera di Padova; Padova Italy

Funder

Care until Cure

Canadian Hemophilia Society

Pfizer

EUHASS

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13167/fullpdf

Reference40 articles.

1. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group;Gringeri;Blood,2003

2. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study;Gouw;Blood,2007

3. Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression;Xi;J Thromb Haemost,2013

4. Harmonization of clinical trial guidelines for assessing the risk of inhibitor development in hemophilia A treatment;Aledort;J Thromb Haemost,2011

5. Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: a critical systematic review;Franchini;Crit Rev Oncol Hematol,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and treatment-related risk factors of inhibitor development after intensive FVIII replacement for major orthopaedic surgery in previous treated haemophilia A;Journal of Orthopaedic Surgery and Research;2024-06-16

2. Managing Relevant Clinical Conditions of Hemophilia A/B Patients;Hematology Reports;2023-06-07

3. Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII;Clinical and Applied Thrombosis/Hemostasis;2023-01

4. Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of time;Transfusion and Apheresis Science;2019-10

5. Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project;Haemophilia;2019-04-16